Evidence map›Paper›PMID 27703042›Full record

SynthesisJournal of psychopharmacology (Oxford, England)2017

The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description.

John McGonigle, Anna Murphy, Louise M Paterson, Laurence J Reed, Liam Nestor, Jonathan Nash, Rebecca Elliott, Karen D Ersche, Remy Sa Flechais, Rexford Newbould and 10 more

Open access · hybridAbstract readMeta-AnalysisMulticenter Study
In one paragraph

Synthesis in Journal of psychopharmacology (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Functional evaluation of NKDrug and alcohol dependence · 2021
    Article
  13. Sobriety and Satiety: Is NAD+ the Answer?Antioxidants (Basel, Switzerland) · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

John McGonigle1 Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK.
Anna Murphy2 Neuroscience and Psychiatry Unit, Institute of Brain, Behaviour and Mental Health, The University of Manchester, Manchester, UK.
Louise M Paterson1 Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK.
Laurence J Reed1 Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK.
Liam Nestor1 Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK.
Jonathan Nash1 Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK.
Rebecca Elliott2 Neuroscience and Psychiatry Unit, Institute of Brain, Behaviour and Mental Health, The University of Manchester, Manchester, UK.
Karen D Ersche3 Department of Psychiatry, University of Cambridge, Cambridge, UK.
Remy Sa Flechais1 Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK.
Rexford Newbould5 Imanova Limited, London, UK.
Csaba Orban1 Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK.
Dana G Smith4 Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.
Eleanor M Taylor2 Neuroscience and Psychiatry Unit, Institute of Brain, Behaviour and Mental Health, The University of Manchester, Manchester, UK.
Adam D Waldman6 Centre for Neuroinflammation and Neurodegeneration, Division of Brain Sciences, Imperial College London, London, UK.
Trevor W Robbins4 Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.
Jf William Deakin2 Neuroscience and Psychiatry Unit, Institute of Brain, Behaviour and Mental Health, The University of Manchester, Manchester, UK.
David J Nutt1 Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK.
Anne R Lingford-Hughes1 Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK.
John Suckling3 Department of Psychiatry, University of Cambridge, Cambridge, UK.
ICCAM Platform
Imperial College London · GBUniversity of Manchester · GBUniversity of Cambridge · GBCambridgeshire and Peterborough NHS Foundation Trust · GBLivaNova (United Kingdom) · GB

Funding

Medical Research Council G1000018Wellcome Trust
6 · The paper itself

Abstract

objectivesWe aimed to set up a robust multi-centre clinical fMRI and neuropsychological platform to investigate the neuropharmacology of brain processes relevant to addiction - reward, impulsivity and emotional reactivity. Here we provide an overview of the fMRI battery, carried out across three centres, characterizing neuronal response to the tasks, along with exploring inter-centre differences in healthy participants. EXPERIMENTAL

designThree fMRI tasks were used: monetary incentive delay to probe reward sensitivity, go/no-go to probe impulsivity and an evocative images task to probe emotional reactivity. A coordinate-based activation likelihood estimation (ALE) meta-analysis was carried out for the reward and impulsivity tasks to help establish region of interest (ROI) placement. A group of healthy participants was recruited from across three centres (total n=43) to investigate inter-centre differences. Principle observations: The pattern of response observed for each of the three tasks was consistent with previous studies using similar paradigms. At the whole brain level, significant differences were not observed between centres for any task.

conclusionsIn developing this platform we successfully integrated neuroimaging data from three centres, adapted validated tasks and applied whole brain and ROI approaches to explore and demonstrate their consistency across centres.

Indexed as

AdultBehavior, AddictiveBiomedical ResearchBrainCase-Control StudiesEmotionsFemaleHumansImpulsive BehaviorLikelihood FunctionsMagnetic Resonance ImagingMaleMiddle AgedMotivationPharmaceutical PreparationsRewardPharmaceutical PreparationsBrainhumanmagnetic resonance imagingsubstance-related disorders

Identifiers

PMID27703042
PMCPMC5367542
OpenAlexW2528225122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.